Benlysta 400mg (Belimumab Vials) 400mg

Benlysta 400mg vials contain belimumab, a prescription biologic for systemic lupus erythematosus and lupus nephritis. This 400mg single-dose vial supports targeted immune modulation under medical supervision. Store between 2–8°C to maintain stability. Always follow healthcare provider guidance when using this medication.

Strength

400mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

GlaxoSmithKline UK Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Belimumab is used to reduce disease activity in adults with active systemic lupus erythematosus or lupus nephritis who are receiving standard therapy. It works by targeting specific immune cells to help control inflammation and symptoms. This medication is prescribed when other treatments have not provided adequate control. It is not a cure but may help manage chronic autoimmune conditions.

Side Effects

Patients may experience changes in immune response during treatment with belimumab. Some report reduced fatigue, joint pain, or skin rashes as inflammation decreases. Others notice fewer disease flares over time. Individual responses vary widely, and benefits are typically assessed over several months of consistent use.

Precautions & Warnings

Keep Benlysta 400mg vials refrigerated between 2–8°C and protect from light. Do not freeze or shake the vial. Use only as directed by a healthcare professional. Inform your provider about any infections or vaccinations before starting treatment. Avoid starting belimumab if you have an active serious infection.

Avoid Interactions

Belimumab may interact with other biologics or immunosuppressants, potentially increasing infection risk. Live vaccines should be avoided during and shortly after treatment. Caution is advised when combining with other immune-modulating therapies. Always disclose all medications to your doctor to assess compatibility. Alcohol use does not directly interact but may affect overall health during immune therapy.

Frequently Asked Questions

Benlysta 400mg is used to treat adults with active systemic lupus erythematosus or lupus nephritis alongside standard therapy.

Belimumab is given as an intravenous infusion by a healthcare provider, typically in a clinic or hospital setting.

No, Benlysta 400mg vials must be refrigerated between 2–8°C and protected from light until use.

Belimumab helps manage lupus symptoms and reduce disease activity but is not a cure for systemic lupus erythematosus.

Inform your doctor about any infections, vaccinations, or other medications you are taking before starting belimumab therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.